First Trust Advisors LP Decreases Stock Holdings in Cardinal Health, Inc. $CAH

First Trust Advisors LP lowered its stake in Cardinal Health, Inc. (NYSE:CAH) by 18.0% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 191,943 shares of the company’s stock after selling 42,035 shares during the quarter. First Trust Advisors LP’s holdings in Cardinal Health were worth $40,559,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Norges Bank acquired a new position in Cardinal Health in the 4th quarter valued at $790,344,000. Wellington Management Group LLP grew its holdings in shares of Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares in the last quarter. Marshall Wace LLP grew its holdings in shares of Cardinal Health by 1,328.1% during the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after buying an additional 884,648 shares in the last quarter. Bessemer Group Inc. raised its position in shares of Cardinal Health by 7,053.4% in the first quarter. Bessemer Group Inc. now owns 750,038 shares of the company’s stock valued at $158,491,000 after buying an additional 739,553 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of Cardinal Health by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after buying an additional 617,775 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CAH has been the topic of a number of recent research reports. Evercore lowered their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. William Blair started coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. UBS Group upped their price objective on shares of Cardinal Health from $260.00 to $274.00 and gave the company a “buy” rating in a report on Monday, July 20th. JPMorgan Chase & Co. cut their price objective on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research report on Monday, May 4th. Finally, Morgan Stanley lifted their target price on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $251.73.

Cardinal Health Trading Up 0.6%

NYSE CAH opened at $229.29 on Tuesday. The stock has a fifty day simple moving average of $220.57 and a 200-day simple moving average of $214.64. The stock has a market cap of $53.70 billion, a PE ratio of 35.06, a P/E/G ratio of 1.11 and a beta of 0.49. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $243.21.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same period in the previous year, the firm earned $2.35 EPS. Cardinal Health’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts predict that Cardinal Health, Inc. will post 10.77 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were issued a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s payout ratio is 31.50%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.